225 related articles for article (PubMed ID: 23441166)
1. Bridging cancer biology with the clinic: relative expression of a GRHL2-mediated gene-set pair predicts breast cancer metastasis.
Yang X; Vasudevan P; Parekh V; Penev A; Cunningham JM
PLoS One; 2013; 8(2):e56195. PubMed ID: 23441166
[TBL] [Abstract][Full Text] [Related]
2. Dual roles of the transcription factor grainyhead-like 2 (GRHL2) in breast cancer.
Werner S; Frey S; Riethdorf S; Schulze C; Alawi M; Kling L; Vafaizadeh V; Sauter G; Terracciano L; Schumacher U; Pantel K; Assmann V
J Biol Chem; 2013 Aug; 288(32):22993-3008. PubMed ID: 23814079
[TBL] [Abstract][Full Text] [Related]
3. The GRHL2/ZEB Feedback Loop-A Key Axis in the Regulation of EMT in Breast Cancer.
Mooney SM; Talebian V; Jolly MK; Jia D; Gromala M; Levine H; McConkey BJ
J Cell Biochem; 2017 Sep; 118(9):2559-2570. PubMed ID: 28266048
[TBL] [Abstract][Full Text] [Related]
4. Grhl2 determines the epithelial phenotype of breast cancers and promotes tumor progression.
Xiang X; Deng Z; Zhuang X; Ju S; Mu J; Jiang H; Zhang L; Yan J; Miller D; Zhang HG
PLoS One; 2012; 7(12):e50781. PubMed ID: 23284647
[TBL] [Abstract][Full Text] [Related]
5. Identification of lineage-specific epigenetic regulators FOXA1 and GRHL2 through chromatin accessibility profiling in breast cancer cell lines.
Yang L; Kumegawa K; Saeki S; Nakadai T; Maruyama R
Cancer Gene Ther; 2024 May; 31(5):736-745. PubMed ID: 38429368
[TBL] [Abstract][Full Text] [Related]
6. SAP domain-dependent Mkl1 signaling stimulates proliferation and cell migration by induction of a distinct gene set indicative of poor prognosis in breast cancer patients.
Gurbuz I; Ferralli J; Roloff T; Chiquet-Ehrismann R; Asparuhova MB
Mol Cancer; 2014 Feb; 13():22. PubMed ID: 24495796
[TBL] [Abstract][Full Text] [Related]
7. GRHL2-controlled gene expression networks in luminal breast cancer.
Wang Z; Coban B; Wu H; Chouaref J; Daxinger L; Paulsen MT; Ljungman M; Smid M; Martens JWM; Danen EHJ
Cell Commun Signal; 2023 Jan; 21(1):15. PubMed ID: 36691073
[TBL] [Abstract][Full Text] [Related]
8. GRHL2 Regulation of Growth/Motility Balance in Luminal versus Basal Breast Cancer.
Wang Z; Coban B; Liao CY; Chen YJ; Liu Q; Danen EHJ
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768838
[TBL] [Abstract][Full Text] [Related]
9. Suppression of the grainyhead transcription factor 2 gene (GRHL2) inhibits the proliferation, migration, invasion and mediates cell cycle arrest of ovarian cancer cells.
Faddaoui A; Sheta R; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Gobeil S; Morin C; Ghani K; Bachvarov D
Cell Cycle; 2017 Apr; 16(7):693-706. PubMed ID: 28278050
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-mesenchymal transition and tumor suppression are controlled by a reciprocal feedback loop between ZEB1 and Grainyhead-like-2.
Cieply B; Farris J; Denvir J; Ford HL; Frisch SM
Cancer Res; 2013 Oct; 73(20):6299-309. PubMed ID: 23943797
[TBL] [Abstract][Full Text] [Related]
11. Disruption of super-enhancer-driven tumor suppressor gene RCAN1.4 expression promotes the malignancy of breast carcinoma.
Deng R; Huang JH; Wang Y; Zhou LH; Wang ZF; Hu BX; Chen YH; Yang D; Mai J; Li ZL; Zhang HL; Huang Y; Peng XD; Feng GK; Zhu XF; Tang J
Mol Cancer; 2020 Aug; 19(1):122. PubMed ID: 32771023
[TBL] [Abstract][Full Text] [Related]
12. GRHL2 inhibits colorectal cancer progression and metastasis via oppressing epithelial-mesenchymal transition.
Yang Z; Wu D; Chen Y; Min Z; Quan Y
Cancer Biol Ther; 2019; 20(9):1195-1205. PubMed ID: 31063022
[TBL] [Abstract][Full Text] [Related]
13. Grainyhead-like-2, an epithelial master programmer, promotes interferon induction and suppresses breast cancer recurrence.
MacFawn I; Farris J; Pifer P; Margaryan NV; Akhter H; Wang L; Dziadowicz S; Denvir J; Hu G; Frisch SM
Mol Immunol; 2024 Jun; 170():156-169. PubMed ID: 38692097
[TBL] [Abstract][Full Text] [Related]
14. Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis.
Papageorgis P; Ozturk S; Lambert AW; Neophytou CM; Tzatsos A; Wong CK; Thiagalingam S; Constantinou AI
Breast Cancer Res; 2015 Jul; 17(1):98. PubMed ID: 26208975
[TBL] [Abstract][Full Text] [Related]
15. Expression of transcription factor grainyhead-like 2 is diminished in cervical cancer.
Torres-Reyes LA; Alvarado-Ruiz L; Piña-Sánchez P; Martínez-Silva MG; Ramos-Solano M; Olimón-Andalón V; Ortiz-Lazareno PC; Hernández-Flores G; Bravo-Cuellar A; Aguilar-Lemarroy A; Jave-Suarez LF
Int J Clin Exp Pathol; 2014; 7(11):7409-18. PubMed ID: 25550776
[TBL] [Abstract][Full Text] [Related]
16. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W
Gene; 2020 Dec; 762():144974. PubMed ID: 32707305
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of GRHL2 inhibited proliferation and induced apoptosis of colorectal cancer by suppressing the PI3K/Akt pathway.
Hu F; He Z; Sun C; Rong D
Gene; 2019 Jun; 700():96-104. PubMed ID: 30917932
[TBL] [Abstract][Full Text] [Related]
18. Grainyhead-like Protein 2: The Emerging Role in Hormone-Dependent Cancers and Epigenetics.
Reese RM; Harrison MM; Alarid ET
Endocrinology; 2019 May; 160(5):1275-1288. PubMed ID: 30958537
[TBL] [Abstract][Full Text] [Related]
19. Integrative bioinformatics analysis reveals new prognostic biomarkers of clear cell renal cell carcinoma.
Butz H; Szabó PM; Nofech-Mozes R; Rotondo F; Kovacs K; Mirham L; Girgis H; Boles D; Patocs A; Yousef GM
Clin Chem; 2014 Oct; 60(10):1314-26. PubMed ID: 25139457
[TBL] [Abstract][Full Text] [Related]
20. GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modification.
Chung VY; Tan TZ; Tan M; Wong MK; Kuay KT; Yang Z; Ye J; Muller J; Koh CM; Guccione E; Thiery JP; Huang RY
Sci Rep; 2016 Feb; 6():19943. PubMed ID: 26887977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
